Stockscreener 앱 받기
0.193
4.38%
0.0081
시장 영업 전:
.19
-0.003
-1.55%
전일 마감가:
$0.1849
열려 있는:
$0.1875
하루 거래량:
552.41K
Relative Volume:
1.10
시가총액:
$2.13M
수익:
$24,000
순이익/손실:
$-78.06M
주가수익비율:
-0.00666
EPS:
-28.9956
순현금흐름:
$-21.81M
1주 성능:
-19.55%
1개월 성능:
-28.52%
6개월 성능:
-50.13%
1년 성능:
-96.14%
1일 변동 폭
$0.1777
$0.197
1주일 범위
$0.1648
$0.24
52주 변동 폭
$0.1648
$8.40
Catheter Precision Inc. Stock (VTAK) Company Profile
명칭
Catheter Precision Inc.
전화
973 691 2000
주소
1670 Highway 160 West, Suite 205, Fort Mill
VTAK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTAK
Catheter Precision Inc.
|
0.193 | 2.07M | 24,000 | -78.06M | -21.81M | -29.00 |
|
ABT
Abbott Laboratories
|
133.57 | 231.29B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.17 | 157.07B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.86 | 146.67B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.74 | 104.07B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.10 | 44.71B | 5.54B | 4.18B | 623.10M | 7.00 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-08-13 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2018-11-02 | 개시 | Maxim Group | Buy |
Catheter Precision Inc. 주식(VTAK)의 최신 뉴스
Catheter Precision, Inc. Receives Ce Mark for LockeT - marketscreener.com
Catheter Precision (VTAK) Achieves CE Mark Approval for LockeT D - GuruFocus
Catheter Precision Receives CE Mark Approval for LockeT Vascular Closure Device - marketscreener.com
Catheter Precision, Inc. Receives CE Mark for LockeT | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Receives CE Mark Approval for LockeT, Expanding Market Opportunities in Europe - Nasdaq
Catheter Precision, Inc. Receives CE Mark for LockeT - The Manila Times
Catheter Precision Unlocks $4.3B European Market with CE Mark: First Orders Already Flowing - Stock Titan
Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews
Why Urban Outfitters Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Catheter Precision Inc Files For Resale Of Up To 12.9 Million Shares Of Common Stock By The Selling StockholdersSEC Filing - marketscreener.com
Catheter Precision Enters Market Offering Agreement - MSN
Catheter Precision Enters At Market Offering Agreement With Ladenburg Thalmann & Co. IncSEC Filing - marketscreener.com
QHSLab Signals Debt Restructuring - citybiz
QHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive Growth - TradingView
Breakthrough Patent: How Autonomix Medical's New Nerve-Mapping Tech Could Transform Pain Treatment - Stock Titan
Catheter Precision revenue increases 74% to USD 143K in Q1 2025 - Medical Buyer
Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results - The Manila Times
Catheter Precision Q1 Revenue Surges 74% as Clinical Studies Show 94% Accuracy in Heart Procedures - Stock Titan
Catheter Precision Enters Securities Purchase Agreement - TipRanks
Catheter Precision, Inc. Announces $1.5 Million Private Placemen - GuruFocus
Catheter Precision (VTAK) Secures $1.5M Through Private Equity F - GuruFocus
Interim Financial Results - The Manila Times
Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance | VTAK Stock News - GuruFocus
Catheter Precision (VTAK) Secures $1.5M Through Private Equity Financing | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance - GlobeNewswire
Catheter Precision Finalizes Strategic Cardiac Acquisition - TipRanks
Catheter Precision completes acquisition of Cardionomic heart failure assets - TipRanks
Catheter Precision (VTAK) Subsidiary Acquires Cardionomic's Hear - GuruFocus
Catheter Precision, Inc. Completes Acquisition of Cardionomic Heart Failure Assets - The Manila Times
Medical Breakthrough: Catheter Precision Takes Over Million-Patient Heart Failure Treatment Innovation - Stock Titan
Catheter Precision (VTAK) Reveals Enhanced Clinical Data on VIVO System | VTAK Stock News - GuruFocus
New Clinical Data Presented about VIVO at the 46th Annual Heart Rhythm Association Conference - The Manila Times
Catheter Precision to Attend and Participate in the 46th Heart Rhythm Society - The Manila Times
Catheter Precision Inc [VTAK] Director makes an insider purchase of 3 shares worth 1.0. - knoxdaily.com
Catheter Precision to Attend and Participate in the 46th Heart R - GuruFocus
Catheter Precision to Attend and Participate in the 46th Heart Rhythm Society | VTAK Stock News - GuruFocus
Breakthrough Cardiac Study: Catheter Precision's VIVO System Achieves 94% Accuracy in European Multi-Center Trial - Stock Titan
Catheter Precision to acquire late-stage heart failure treatment assets in development - MSN
Analytical Lens: Exploring Catheter Precision Inc (VTAK)’s Financial Story Through Ratios - DWinneX
Catheter Precision Inc (VTAK) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Can Catheter Precision Inc (VTAK) meet market expectations this quarter? - uspostnews.com
How analysts predict Five9 Inc (FIVN) will perform this quarter? - uspostnews.com
Catheter Precision (VTAK) Acquires Assets for Cardiac Technology Expansion | VTAK Stock News - GuruFocus
Catheter Precision to acquire assets of Cardionomic related to CPNS system - TipRanks
Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure - The Manila Times
Catheter Precision To Acquire Assets In Development For Late-Stage Treatment For Acute Decompensated Heart Failure - marketscreener.com
Breakthrough Heart Failure Treatment Tech With 1M Patient Potential Acquired: Early Clinical Success Revealed - Stock Titan
Catheter Precision Inc. (VTAK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.01%
0.66%
자본화:
|
볼륨(24시간):